Actively Recruiting
Memory Support System for Older Chinese Americans With Mild Cognitive Impairment
Led by Icahn School of Medicine at Mount Sinai · Updated on 2025-11-06
7
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Memory Support System (MSS) from the Healthy Action to Benefit Independence \& Thinking® (HABIT) Program is an evidence-based, non-pharmacological intervention for mild cognitive impairment (MCI). Despite the clinical benefits and feasibility, the MSS was primarily developed and used with non-Hispanic White, English-speaking adults. Racial/ethnic minority groups are chronically under-enrolled in clinical trials for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) due to lack of linguistically and culturally appropriate adaptation of assessment measures and intervention protocols. The purpose of this research study is to examine whether the MSS from HABIT can help Chinese American older adults with mild thinking and memory problems. Target recruitment is 60 Chinese American adults who are primarily Mandarin- (n=30) and Cantonese-speaking (n=30). Forty participants will participate in the trainer-led day planner training and 20 will participate in self-study of the day planner and receive brain health education. Each participant will also be asked to identify a study partner to participate with them.
CONDITIONS
Official Title
Memory Support System for Older Chinese Americans With Mild Cognitive Impairment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Self-identify as Chinese American
- Age 55 years or older
- Diagnosed with mild cognitive impairment confirmed by clinical or research criteria
- Primarily speak Cantonese or Mandarin
- Able to read and write in Chinese
- Have adequate vision and hearing for cognitive testing
- Willing to complete assessment measures
- Have a study partner or informant in regular contact
- No recent changes or stable use of prescribed memory-enhancing medications for at least 3 months
You will not qualify if you...
- Have a significant neurological disease affecting participation
- History of psychiatric disorder diagnosed in the past 12 months
- History of reading or writing disability that interferes with MSS training
- Currently participating in another relevant clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Li Lab, Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
Research Team
C
Clara Li, PhD
CONTACT
X
Xinyi Zhang, MA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here